From: Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
N = 91 (%)
Not available
68 (75)
Tested
23 (25)
EGFR negative
15 (65)
Insufficient material
6 (26)
EGFR positive
2 (9)